Taken together, these data lend to an intriguing suggestion that suppression of NF-κB activation in combination with suppression of the B-raf/Mek/Erk/Stat3 pathway may be a useful strategy in the suppression of cancer progression. This evidence concerns the gene MAP2K7 and cancer.